spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

13th Annual Biomarkers Congress

15-16 February 2018
Manchester Central Convention Complex, Manchester, UK

Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018, Manchester.

The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases.

Attended by over 300 biomarker experts, congress will include representatives from the companies including Bayer, Roche, Merck, UCB, Pfizer. The high quality and outstanding interactive programme includes 2 pre-event webinars, 50 expert presentations, a workshop and 8 round table discussions.

Do not miss out on the latest developments in biomarker innovations, state of the art technologies, and drivers into biomarker development such as precision medicine, immuno-assays and screening processes, histology, immunohistochemistry, big data analytics, new technologies in translation and the prediction of patient population.

View the Agenda here:

http://bit.ly/2v4APod

Free Pre-Congress Live Webinars

Analytical Validation of Assays for the Qualification of Biomarkers
Thursday 19th October 2017 | 10am GMT
Hosted by John Allinson, ‎Head of Biomarker Strategy at Drug Development Services, LGC & Darren Hodgson, Senior Principal Translational Scientist, Oncology iMED, AstraZeneca

Register today for free:

http://bit.ly/2xTtg29

Predictive and Efficacy Biomarkers in Cancer Research
Tuesday 28th November 2018 | 10am GMT
Hosted by Mattias Bergqvist, VP Clinical Development, Biovica International and Sue Burchill, Professor of Adolescent and Paediatric Cancer Research, Leeds Institute of Cancer and Pathology.

Register today for free:

http://bit.ly/2xT7TR9

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

 
Print this page
Send to a friend
   
spacer
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>


News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement